Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lck-IN-2 (compound 12a), an inhibitor of Lymphocyte-specific protein tyrosine kinase (Lck), demonstrates an IC50 of 10.6 nM. It displays efficacy in colon cancer cells, exhibiting GI50 values ranging from 0.24-1.26 μM. Furthermore, Lck-IN-2 induces apoptotic effects in Colo201 cells [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Lck-IN-2 (compound 12a), an inhibitor of Lymphocyte-specific protein tyrosine kinase (Lck), demonstrates an IC50 of 10.6 nM. It displays efficacy in colon cancer cells, exhibiting GI50 values ranging from 0.24-1.26 μM. Furthermore, Lck-IN-2 induces apoptotic effects in Colo201 cells [1]. |
Targets&IC50 | Lck:10.6 nM |
Molecular Weight | 596.64 |
Formula | C31H32N8O5 |
Cas No. | 2615173-24-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.